ClinicalTrials.gov - Information on Clinical Trials and Human Research Studies: Browse: University of California Davis Cancer Center


	Home	\|	Search	\|	Browse	\|	Resources	\|	Help	\|	What's New	\|	About

Include trials that are no longer recruiting patients.

1.	No longer recruiting	BMS-275291 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy Conditions: adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
2.	No longer recruiting	Monoclonal Antibody Therapy Plus Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy Conditions: stage IV prostate cancer; recurrent prostate cancer
3.	No longer recruiting	Monoclonal Antibody Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma Conditions: Burkitt's Lymphoma; Lymphoblastic Lymphoma; Myeloid Leukemia
4.	No longer recruiting	Monoclonal Antibody Therapy, Cyclosporine, and Paclitaxel in Treating Patients With Recurrent or Refractory Metastatic Breast Cancer Conditions: stage IV breast cancer; recurrent breast cancer
5.	No longer recruiting	Monoclonal Antibody Therapy, Paclitaxel, and Cyclosporine in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma Conditions: Burkitt's Lymphoma; Lymphocytic Lymphoma